How often and in what way do you monitor patients who are receiving teprotumumab (Tepezza) for thyroid eye disease?

1 Answers

Mednet Member

Ophthalmology · Jackson Eye Associates

A week or two after completion unless having an issue.

How often and in what way do you monitor patients who are receiving teprotumumab (Tepezza) for thyroid eye disease? | Mednet